The National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) encourage applications for the exploratory/developmental program for translational research in muscular dystrophy.*
The purpose of this announcement is to encourage the development and implementation of translational research programs in muscular dystrophy. Applications should focus on development of tools and resources necessary for conducting a translational research program.
Examples of possible goals of the program include, but are not limited to: identification of targets for therapeutic intervention; development of assays that permit preliminary screening of candidate therapeutics, animal models that permit further evaluation of candidate therapeutics, and tools and technologies that can be directly used for therapy development; preliminary identification of candidate therapeutics that can be evaluated through further preclinical testing; and testing of therapeutics for efficacy in cell-based or animal models of muscular dystrophy.
For more information, potential applicants should contact Dr. John Porter, Program Director, Channels, Synapses, and Circuits Cluster, NINDS, Neuroscience Center, 6001 Executive Boulevard, Room 2142, Bethesda, MD 20892; telephone: 301-496-1917; fax: 301-402-1501; e-mail: firstname.lastname@example.org.
*For a more detailed description of this announcement, please visit the NIH web site at: http://grants.nih.gov/grants/guide/pa-files/PAR-06-043.html.